KEY FEATURES
| Full Name | Programmed Cell Death Protein 6 Interacting Protein |
|---|---|
| Synonym | PDCD6-IP; AIP1; Alix; DRIP4; HP95; ALG-2 Interacting Protein X |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human PDCD6IP in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human PDCD6IP. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PDCD6IP and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PDCD6IP, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human PDCD6IP. You can calculate the concentration of Human PDCD6IP in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human PDCD6IP ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.95 | 2.57 | 7 | 0.99 | 2.35 | 7.38 |
| Standard deviation | 0.05 | 0.1 | 0.35 | 0.05 | 0.1 | 0.3 |
| CV(%) | 5.67 | 4.07 | 5.06 | 5.22 | 4.14 | 4.09 |
RECOVERY
The recovery of Human PDCD6IP spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-104 | 99 |
| EDTA plasma (n=8) | 85-97 | 91 |
| Cell culture media (n=8) | 89-102 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human PDCD6IP in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with PEBP1 ELISA Kits
| IKBKB ELISA Kit | publications with PEBP1 and IKBKB |
| RAF1 ELISA Kit | publications with PEBP1 and RAF1 |
| AURKB ELISA Kit | publications with PEBP1 and AURKB |
| UBC ELISA Kit | publications with PEBP1 and UBC |
Pathways associated with PEBP1 ELISA Kit
| ARMS-mediated Activation Pathway | ARMS-mediated Activation Pathway |
| Aurora B Signaling Pathway | Aurora B Signaling Pathway |
| Axon Guidance Pathway | Axon Guidance Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| DAP12 Interactions Pathway | DAP12 Interactions Pathway |
| DAP12 Signaling Pathway | DAP12 Signaling Pathway |
| Developmental Biology Pathway | Developmental Biology Pathway |
| Disease Pathway | Disease Pathway |
| Diseases Of Signal Transduction Pathway | Diseases Of Signal Transduction Pathway |
| Downstream Signal Transduction Pathway | Downstream Signal Transduction Pathway |
Diseases associated with PEBP1 ELISA Kit
| Carcinoma | publications with PEBP1 and Carcinoma |
| Disease Models, Animal | publications with PEBP1 and Disease Models, Animal |
| Neoplasms, Experimental | publications with PEBP1 and Neoplasms, Experimental |
| Lung Neoplasms | publications with PEBP1 and Lung Neoplasms |
| Nervous System Diseases | publications with PEBP1 and Nervous System Diseases |
| Liver Diseases | publications with PEBP1 and Liver Diseases |
| Liver Neoplasms | publications with PEBP1 and Liver Neoplasms |
| Inflammation | publications with PEBP1 and Inflammation |
| Necrosis | publications with PEBP1 and Necrosis |
| Cardiovascular Diseases | publications with PEBP1 and Cardiovascular Diseases |
Organs/Tissues associated with PEBP1 ELISA Kit
| Prostate | publications with PEBP1 and Prostate |
| Blood | publications with PEBP1 and Blood |
| Brain | publications with PEBP1 and Brain |
| Liver | publications with PEBP1 and Liver |
| Lymph Node | publications with PEBP1 and Lymph Node |
| Lymph | publications with PEBP1 and Lymph |
| Vascular | publications with PEBP1 and Vascular |
| Lung | publications with PEBP1 and Lung |
| Stomach | publications with PEBP1 and Stomach |
| Skin | publications with PEBP1 and Skin |